Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Analgesics Market Size, Value And Growth Trajectory Through 2030
The analgesics market has experienced consistent growth in recent years. This market is projected to expand from $113.1 billion in 2025 to $115.82 billion in 2026, at a compound annual growth rate (CAGR) of 2.4%. The growth observed in the historic period can be attributed to an increase in global musculoskeletal disorders, a rise in surgical procedures, growing cancer incidence, the expansion of hospital infrastructure, and the widespread availability of generic analgesics.
The analgesics market is anticipated to experience consistent expansion over the upcoming years, with projections indicating a rise to $132.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.4%. This projected growth throughout the forecast period stems from factors such as progress in personalized medicine, enhanced research and development into opioid alternatives, the expansion of e-pharmacies and digital healthcare services, an increasing elderly demographic, and the incorporation of smart manufacturing within the pharmaceutical sector. Key developments expected during this period involve tailored pain management approaches, an increase in the development of both opioid and non-opioid medications, wider accessibility through hospital and retail pharmacy networks, a heightened need for chronic and cancer pain treatments, and greater public understanding of responsible analgesic consumption.
Get A Free Sample Report With In-Depth Market Insights:
Analgesics Market Demand Drivers: What’s Powering Industry Growth?
The increasing healthcare spending is anticipated to fuel the expansion of the analgesics market moving ahead. These expenditures encompass all expenses related to delivering health services, family planning activities, nutritional initiatives, and emergency aid, all centered on health. An uptick in healthcare spending stimulates pharmaceutical research and development, leading to novel and enhanced analgesic medications. As an illustration, the Office for National Statistics, a UK-based government department, reported in May 2024 that overall healthcare spending nominally increased by 5.6% from 2022 to 2023. Consequently, the escalation in healthcare expenditures is propelling the growth of the analgesics market.
Analgesics Market Segment Breakdown: Which Categories Lead On Revenue?
The analgesics market covered in this report is segmented –
1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
Analgesics Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies within the analgesic market are increasingly prioritizing the introduction of combination pain relievers to secure a competitive edge. These combination analgesics are medications featuring a blend of two or more distinct pain-alleviating drugs, often formulated to deliver more potent pain relief by engaging multiple mechanisms. For instance, in February 2024, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, launched COMBOGESIC IV (acetaminophen and ibuprofen) in the United States. COMBOGESIC IV is an intravenous formulation that unites acetaminophen (paracetamol) and ibuprofen, offering dual-action pain relief through the combined analgesic and anti-inflammatory properties of both medications. Positioned as a new non-opioid choice for pain management, this intravenous formulation administers 1,000 mg of acetaminophen and 300 mg of ibuprofen, providing a potent alternative amidst increasing worries about opioid usage. COMBOGESIC IV offers over twice the pain relief compared to its individual components, along with a more rapid onset and a commendable safety profile.
Analgesics Market Leading Players And Competitive Positioning
Major companies operating in the analgesics market are Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC
View The Full Analgesics Market Report:
Analgesics Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the analgesics market in 2025. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model